State Street SPDR S&P Biotech ETF
ETFYour view on XBI
State Street SPDR S&P Biotech ETF
ETFSPDRSentiment
AUM (USD)
$10.16B
Expense Ratio
0.35%
Holdings
155
Sentiment
Overview for State Street SPDR S&P Biotech ETF
- Fund Type
- ETF
- Fund Issuer
- SPDR
- Asset Class
- Equity
- Sector
- Financial Services
- Industry
- Asset Management
- Inception Date
- January 31, 2006
- Domicile
- US
- Fund Type
- ETF
- Fund Issuer
- SPDR
- Asset Class
- Equity
- Sector
- Financial Services
- Industry
- Asset Management
- Inception Date
- January 31, 2006
- Domicile
- US
- Fund Type
- ETF
- Fund Issuer
- SPDR
- Asset Class
- Equity
- Sector
- Financial Services
- Industry
- Asset Management
- Inception Date
- January 31, 2006
- Domicile
- US
About this fund
The State Street SPDR S&P Biotech ETF seeks to provide investment results that, before fees and expenses, correspond generally to the total return performance of the S&P Biotechnology Select Industry Index (the "Index")Seeks to provide exposure to the Biotechnology segment of the…
XBI Stock Price
Key Facts
EquityExpense Ratio
0.35%
AUM
$10.16B
Fund Details
Expense Ratio
0.35%
Assets Under Management
$10.16B
NAV
$154.57 USD
Holdings
155
Average Volume
8.89M
Inception Date
January 31, 2006
Asset Class
Equity
Fund Issuer
SPDR
Domicile
US
ISIN
US78464A8707
CUSIP
78464A870
NAV Currency
USD
Expense Ratio
0.35%
Assets Under Management
$10.16B
NAV
$154.57 USD
Holdings
155
Average Volume
8.89M
Inception Date
January 31, 2006
Asset Class
Equity
Fund Issuer
SPDR
Domicile
US
ISIN
US78464A8707
CUSIP
78464A870
NAV Currency
USD
Latest headlines and company announcements for this company. Press releases and market coverage, newest first.
News
this company valued side by side against its closest peers. Peer-relative multiples and operating metrics, so the valuation is read in the context of its own sector rather than in isolation.